Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013;28(3-4):264-78.
doi: 10.1080/19371918.2013.759031.

Medications for substance use disorders

Antoine B Douaihy  1 , Thomas M Kelly, Carl Sullivan
Affiliations
Review

Medications for substance use disorders

Antoine B Douaihy et al. Soc Work Public Health. 2013.

Abstract

In this article, the authors briefly review the pharmacotherapeutic agents that are currently available for the treatment of substance use disorders. Nicotine replacement therapies are most effective for tobacco cessation. Naltrexone, acamprosate, and disulfiram are effective for reducing alcohol use. The most effective pharmacotherapies for opiate use disorders are agonist therapies, including methadone and buprenorphine. The authors also examine recent advances in medication development for other substance use disorders such as stimulant addiction. The role of medication adherence and behavioral treatments and the integration of behavioral and pharmacotherapeutic interventions are also discussed.

PubMed Disclaimer

References

    1. Anton RF. Pharmacologic approaches to the management of alcoholism. Journal of Clinical Psychiatry. 2001;62(Suppl 20):11–17. - PubMed
    1. Anton RF, O’Malley SS, Ciraulo DA, Couper D, Donovan DM, Gastfriend DR COMBINE Study Research Group. Combined pharmacotherapies and behavioral interventions for alcohol dependence. The COMBINE study: A randomized controlled trial. Journal of the American Medical Association. 2006;295:2003–2017. - PubMed
    1. Banys P. The clinical use of disulfiram (Antabuse): A review. Journal of Psychoactive Drugs. 1988;20(3):243–261. - PubMed
    1. Barber WS, O’Brien CP. Pharmacotherapies. In: McCrady BS, Epstein EE, editors. Addictions: A comprehensive guidebook. New York, NY: Oxford University Press; 1999. pp. 347–369.
    1. Batki SL, Kauffman JF, Marion I, Parrino MW, Woody GE. Medication assisted treatment for opioid addiction in opioid treatment programs. Vol. 43. Rockville, MD: Center for Substance Abuse Treatment; 2005. TIP series. - PubMed

MeSH terms